1·Objective To evaluate the value of intraperitoneal chemotherapy in moderate advanced gastrointestinal cancer.
目的探讨腹腔内化疗在中晚期胃肠癌治疗中的价值。
2·Administration approach included intratumoral injection, intrabronchial drop in, intraperitoneal injection, intra-arterial infusion and intravenous drip.
给药途径包括瘤内注射、支气管内喷洒、腹腔内注射、动脉灌注和静脉滴注。
3·Results Laparoscopic mesh herniorrhaphy was successfully performed in 6 patients, while a conversion to open herniorrhaphy was required in 1 patient because of extensive intraperitoneal adhesion.
结果6例修补成功，1例因腹腔内广泛致密粘连而中转为剖腹缝合修补。
4·Intraoperative or postoperative adjuvant to be intraperitoneal chemotherapy, and radiotherapy and BRM with adjuvant therapy.
术中或术后早期应给辅助性腹腔内化疗，并配合放疗及BRM辅助治疗。
5·Objective to determine the clinical value of intraperitoneal hyperthermic perfusion (IPHP) chemotherapy in preventing postoperative recurrence of advanced colorectal cancer.
目的探讨术中腹腔内温热灌注(IPHP)化疗在中晚期大肠癌中的临床价值。
1·All intraperitoneal surfaces should be carefully inspected and suspicious areas or adhesions should be biopsied.
所有的腹膜内表面要仔细检查，可疑区域或粘着物应送活组织检查。
2·Patients undergoing cytoreductive surgery combined with intraperitoneal chemotherapy are required to be in the lithotomy position for many hours.
患者在接受细胞减数外科治疗合并腹膜内化疗时要求保持截石位几个小时。